BIRMINGHAM, Alabama – Evonik Corp. officials today announced that significant new investments in the company’s Birmingham labs will add extensive manufacturing and R&D capabilities while also creating more than 50 high-paying jobs.
Following $50 million in investments over the past four years, the Birmingham site is now home to Evonik’s global Competence Center for Medical Devices, which aims to develop new system solutions for medical technology and to expand the competencies of Evonik in the areas of biomaterials and medical polymers.
In addition, the company said it is installing a new, high-speed fill line for its extended-release drug delivery business, which focuses on polymer-based microparticles administered through injection or IV.



